Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sol-Gel 5-FU Cream vs Efudex in Actinic Keratosis
NCT03727074Phase 3Completed
- Sponsor
- Sol-Gel Technologies
- Start
- Dec 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluorouracil 5% cream in actinic keratosis (AK) (3 arms), sponsored by Sol-Gel Technologies. Primary endpoint: Treatment Success at Week 6. Started Dec 2018; status: completed.
02
Drugs
fluorouracil 5% cream
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT03727074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03727074.